The outbreak of COVID-19 is leading to a tremendous search for curative treatments. The urgency of the situation favors a repurposing of active drugs but not only antivirals. This short communication focuses on four treatments recommended by WHO and included in the first clinical trial of the European Discovery project.
Keywords: COVID-19; SARS-CoV-2; chloroquine; hydroxychloroquine; lopinavir/ritonavir; remdesivir; repurposing.